LH

LabcorpC

NYSE / Health Care Equipment & Services

At close

2026-06-03

View Chart

AI scenario view

RankAlpha Sentiment AI

B+

Bull case

20%

Probability

Target price

$359.10

+38.7% vs current

Most likely

Base case

60%

Probability

Target price

$304.32

+17.5% vs current

B-

Bear case

20%

Probability

Target price

$260.00

+0.4% vs current

AI sentiment snapshot

Latest data as of 2026-02-19

AI commentary

Consensus is modestly positive: the analyst median ($304.32) sits above the anchor ($278.76), implying measured upside but not consensus conviction [#SERP-1][#SERP-5]. The wide analyst range (low $260.00 — high $359.1) reflects disagreement over timing and durability of volume recovery and reimbursement risk [#SERP-2]. Near-term direction will be driven by quarterly results, guidance clarity, and any regulatory/8‑K developments.

RankAlpha Sentiment AI - 2026-02-19

Open full AI memo

Evidence flagged

No evidence quality warning is currently attached to this memo.

Impact

standard

Confidence

AI events

2026-05-20catalystNext quarterly earnings (Q1 2026)Medium impact

Upcoming quarterly report may reset guidance and reveal testing volume trends; market typically moves on organic test volumes and margin commentary [#SERP-4].

2026-06-30eventReimbursement/regulatory decision riskHigh impact

Potential changes to reimbursement or major contract outcomes could materially reduce volumes or margins; timing uncertain—assumed near mid‑2026 for planning purposes [#SERP-6].

2027-02-19catalyst12-month analyst consensus repricingHigh impact

Analyst target updates and revisions (consensus median ~$304.32) over the next 12 months could drive multi‑month re‑rating [#SERP-1][#SERP-5].

View full catalyst timeline

Recommendation

N/A

No formal recommendation provided.

Open AI Memo

As of 2026-02-19 • Updated nightlySource: Internal modelMethodology